Jan 29 |
Cosmos Health files to sell up to 4.87M shares of common stock for holder
|
Jan 23 |
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
|
Jan 18 |
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
|
Dec 27 |
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
|
Dec 20 |
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
|
Dec 18 |
Cosmos Health CEO to purchase up to $3M in common shares; stock rises
|
Dec 18 |
Cosmos Health Announces Open Market Stock Purchases by the CEO
|
Dec 8 |
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
|
Dec 7 |
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
|
Dec 1 |
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
|